NCT05571618
The Rechallenge of ADCs in MBC Patients
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 2 with changes below, 1 re-verified with no change.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Active, Not Recruiting
- Minor Primary completion date: Sep 1, 2024 to Jan 1, 2025
- Study completion date: Sep 1, 2024 to Mar 1, 2025
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
PFS
Timeframe: 6 weeks
Secondary (5)
ORR
CBR
DoR
Adverse events
OS
Arms and interventions
Group1
Drugs: ADC
Sites
1 site in 1 country
- Fudan University Shanghai Cancer CenterShanghai, Shanghai Municipality, China